SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.60    0.05 (3.23%)
Bid:
1.60
Ask:
2.00
Spread: 0.40 (25.00%)
Market Cap: £5.61m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Proteome News

Proteome Sciences shares rise as chair hails rebound in business
16 May 2025

Proteome Sciences shares rise as chair hails rebound in business

(Alliance News) - Proteome Sciences PLC on Friday said demand for its proteomics business has "rebounded strongly" and it is optimistic for the future...

EARNINGS: Devolver Digital loss narrows; Sound Energy loss widens
10 Apr 2025

EARNINGS: Devolver Digital loss narrows; Sound Energy loss widens

Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News:

Proteome secures $1m-plus contract with US biopharma firm
21 Feb 2025

Proteome secures $1m-plus contract with US biopharma firm

(Sharecast News) - Proteome Sciences announced on Friday that it has secured a contract worth over $1m from a US biopharmaceutical company for the use...

Proteome Sciences wins spectometry contract worth over USD1 million
21 Feb 2025

Proteome Sciences wins spectometry contract worth over USD1 million

(Alliance News) - Proteome Sciences PLC on Friday said it has won a contract from a US biopharmaceutical company worth over USD1 million.

AIM WINNERS & LOSERS: Proteome wins deal; Biome plots AIM exit
21 Feb 2025

AIM WINNERS & LOSERS: Proteome wins deal; Biome plots AIM exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Proteome Sciences gives bullish outlook for 2025
23 Dec 2024

Proteome Sciences gives bullish outlook for 2025

(Sharecast News) - Shares in drug development services group Proteome Sciences rose on Monday after the company said 2024 results should reflect a goo...